Drug Shortage Report for TADALAFIL
Report ID | 17354 |
Drug Identification Number | 02455374 |
Brand name | TADALAFIL |
Common or Proper name | TADALAFIL |
Company Name | PRO DOC LIMITEE |
Market Status | MARKETED |
Active Ingredient(s) | TADALAFIL |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 4 |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2018-11-02 |
Estimated end date | |
Actual end date | 2018-12-11 |
Shortage status | Resolved |
Updated date | 2018-12-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v21 | 2018-12-11 | English | Compare |
v22 | 2018-12-11 | French | Compare |
v23 | 2018-12-12 | English | Compare |